Notably, overexpression of ESR1 promoted breast cancer cell proliferation, migration, and invasion; however, these results were reversed upon knocking down ESR1. The observed inhibitory effect of isorhamnetin on breast cancer cells was attributed to its ability to suppress ESR1 gene expression (22). This evidence concerns the gene ESR1 and breast carcinoma.